Construct: ORF ccsbBroadEn_10253
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF013337.1_s300c1, BRDN0000391276
- DNA Barcode:
- None
- Epitope Tag:
- None
- Notes:
- No stop codon in insert
Originally Annotated References:
- Gene:
- ALG13 (79868)
Vector Information:
- Vector Backbone:
- pDONR223
- Pol II Cassette 1:
- n/a
- Pol II Cassette 2:
- n/a
- Selection Marker:
- n/a
- Visible Reporter:
- n/a
- Epitope Tag:
- n/a
Current transcripts matched by this ORF:
Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
---|---|---|---|---|---|---|---|---|
1 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | XM_017029855.1 | 80.1% | 80.1% | 1_342del |
2 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | XM_017029854.2 | 74.8% | 74.8% | 1_153del;813_884del;1122_1358del |
3 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | XM_011531037.1 | 68.6% | 68.6% | 1_321del;981_1052del;1290_1526del |
4 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | XM_017029853.1 | 67.8% | 67.8% | 1_342del;1002_1073del;1311_1547del |
5 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | XM_017029852.1 | 54.7% | 54.7% | 1_828del;1488_1559del;1797_2033del |
6 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | XM_017029851.1 | 51.3% | 51.3% | 1_993del;1653_1724del;1962_2198del |
7 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | NM_001324293.1 | 51.2% | 51.2% | 1_1311del |
8 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | NM_001257230.2 | 48.1% | 48.1% | 1_1485del |
9 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | NM_001257234.1 | 48.1% | 48.1% | 1_1485del |
10 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | NM_001257237.1 | 48.1% | 48.1% | 1_1485del |
11 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | XM_011531034.2 | 47.9% | 47.9% | 1_1188del;1848_1919del;2157_2393del |
12 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | XM_006724697.3 | 43.4% | 43.4% | 1_1485del;2145_2216del;2454_2690del |
13 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | XM_006724698.3 | 43.4% | 43.4% | 1_1485del;2145_2216del;2454_2690del |
14 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | XM_011531031.1 | 43.4% | 43.4% | 1_1485del;2145_2216del;2454_2690del |
15 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | XM_011531032.1 | 43.4% | 43.4% | 1_1485del;2145_2216del;2454_2690del |
16 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | XM_011531033.3 | 43.4% | 43.4% | 1_1485del;2145_2216del;2454_2690del |
17 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | NM_001324292.2 | 43.3% | 43.3% | 1_1797del |
18 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | NM_001257231.1 | 43.3% | 43.3% | 1_1563del;2460_2696del |
19 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | XM_017029848.1 | 42.6% | 42.6% | 1_1797del;1973_1974ins24 |
20 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | XM_011531030.2 | 42.4% | 42.4% | 1_1797del;2457_2528del |
21 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | NM_001099922.3 | 40.3% | 40.3% | 1_1797del;2694_2930del |
22 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | XM_017029847.1 | 39.6% | 38.9% | (many diffs) |
23 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | XM_011531028.2 | 39.5% | 39.5% | 1_1797del;2457_2528del;2766_3002del |
24 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | XM_006724693.3 | 39.2% | 39.2% | 1_1797del;2456_2457ins39;2655_2891del |
25 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | XM_017029846.1 | 38.8% | 38.8% | (many diffs) |
26 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | NR_148693.2 | 38.7% | 1_1525del;2903_3555del | |
27 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | XM_024452449.1 | 29.5% | 28.7% | (many diffs) |
28 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | XM_017029849.1 | 28.9% | 28% | (many diffs) |
29 | human | 79868 | ALG13 | ALG13 UDP-N-acetylglucosami... | XM_017029850.2 | 27.7% | 27.7% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 69
- ORF end:
- 1446
- ORF length:
- 1377
- Sequence:
-
1 gttcgttgca acaaattgat gagcaatgct tttttataat gccaacttTG TACAAAAAAG 61 TTGGCACCAT GACTATGGCT TACGGCAAGG GAGACCCCCT CCTCCCACCC AGGCTGCAGC 121 ACAGTATGCA TTATGGGCAC GATCCTCCAA TGCACTACTC ACAGACAGCT GGCAATGTTA 181 TGTCTAATGA ACATTTTCAT CCTCAGCATC CATCTCCGAG ACAAGGTCGG GGATATGGGA 241 TGCCCAGGAA TTCATCTCGG TTTATAAACA GGCACAACAT GCCGGGCCCT AAAGTTGATT 301 TTTACCCAGG CCCAGGTAAA AGGTGCTGCC AGAGCTATGA TAACTTCTCT TATAGATCTC 361 GTTCATTTAG ACGTAGTCAC CGCCAGATGA GTTGTGTGAA TAAGGAGTCC CAGTATGGAT 421 TTACCCCAGG GAATGGACAG ATGCCCAGGG GCTTGGAAGA AACTATTACT TTTTATGAAG 481 TTGAAGAAGG GGATGAGACT GCTTATCCAA CTTTACCTAA TCATGGAGGT CCCTCTACAA 541 TGGTTCCTGC TACTTCAGGA TACTGTGTTG GAAGGCGGGG ACATAGCTCA GGCAAACAGA 601 CTTTGAATTT AGAGGAGGGC AATGGCCAGA GTGAAAATGG GCGATATCAT GAAGAATATC 661 TTTATCGTGC AGAGCCAGAC TATGAAACTT CAGGTGTTTA TAGCACAACT GCATCTACAG 721 CAAACTTGTC TCTTCAGGAC AGAAAGTCAT GTTCTATGTC TCCTCAGGAC ACAGTTACCT 781 CATACAACTA CCCCCAGAAG ATGATGGGAA ATATTGCAGC AGTTGCAGCT TCCTGTGCCA 841 ATAATGTTCC AGCTCCAGTC TTATCTAACG GTGCAGCGGC TAATCAAGCT ATTAGTACCA 901 CTTCAGTTTC CTCACAGAAT GCTATACAGC CTCTCTTTGT ATCTCCACCT ACACACGGCA 961 GGCCAGATAC AAAAGTTTTG CAGTACTATT TCAATCTAGG ATTGCAGTGC TATTACCACA 1021 GCTACTGGCA CTCCATGGTC TATGTGCCAC AGATGCAGCA GCAGCTTCAT GTAGAGAATT 1081 ATCCAGTCTA TACTGAGCCA CCTCTGGTAG ATCAAACCGT TCCTCAATGC TACAGTGAGG 1141 TGAGGAGAGA AGATGGCATA CAGGCGGAAG CATCAGCAAA TGATACTTTT CCGAATGCTG 1201 ATTCTTCATC TGTCCCTCAT GGAGCAGTCT ATTATCCAGT AATGTCAGAT CCCTATGGGC 1261 AGCCACCTTT GCCAGGTTTT GACTCCTGCC TTCCGGTTGT GCCAGATTAT TCCTGTGTTC 1321 CCCCCTGGCA TCCAGTTGGT ACAGCATATG GTGGTTCTTC TCAAATTCAT GGTGCTATAA 1381 ATCCTGGGCC AATTGGCTGT ATTGCTCCAT CTCCCCCAGC TTCTCATTAT GTACCTCAGG 1441 GTATGTTGCC AACTTTCTTG TACAAAGTtg gcattataag aaagcattgc ttatcaattt 1501 gttgcaacga ac